GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (XCNQ:IAN) » Definitions » Valuation Rank

iAnthus Capital Holdings (XCNQ:IAN) Valuation Rank


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

iAnthus Capital Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

iAnthus Capital Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (XCNQ:IAN) » Definitions » Valuation Rank
Comparable Companies
XCNQ:LEEF TSX:AVCN NEOE:CBST TSXV:DB TSXV:ROMJ TSXV:LSL XCNQ:CXXI XCNQ:AYR.A XCNQ:GWAY TSXV:VM ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
ITHUF:USA 2IA:Germany
Address
214 King Street, Suite 314, Toronto, ON, CAN, M5H 3S6
Website
https://www.ianthus.com
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Alexander Azim Shoghi Director
Elizabeth M. Stavola Director, Senior Officer
Jr. Robert Michael Whelan Director
Hadley Ford Director, Senior Officer
Randy Maslow Director, Senior Officer
Patrick Tiernan Senior Officer
Julius John Kalcevich Senior Officer